Authors’ Reply to Sibel Yöntem and Colleagues’ Comment on “Indigenous Medicine Use for Sex Selection During Pregnancy and Risk of Congenital Malformations: A Population-Based Case-Control Study in Haryana, India”

Sutapa Bandyopadhyay Neogi (), Preeti H. Negandhi, Ravi Kant Gupta, Abhijit Ganguli, Sanjay Zodpey, Amarjeet Singh and Rakesh Gupta
Additional contact information
Sutapa Bandyopadhyay Neogi: Indian Institute of Public Health–Delhi (IIPH–D), Public Health Foundation of India (PHFI)
Preeti H. Negandhi: Indian Institute of Public Health–Delhi (IIPH–D), Public Health Foundation of India (PHFI)
Ravi Kant Gupta: National Health Mission
Abhijit Ganguli: Thapar University
Sanjay Zodpey: Indian Institute of Public Health–Delhi (IIPH–D), Public Health Foundation of India (PHFI)
Amarjeet Singh: Post Graduate Institute of Medical Education and Research
Rakesh Gupta: National Health Mission

Drug Safety, 2016, vol. 39, issue 1, No 10, 92 pages

Date: 2016
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-015-0356-y Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:39:y:2016:i:1:d:10.1007_s40264-015-0356-y

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-015-0356-y

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().